Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

201153 citationsJournal Article

Authors

Good health and well-being

Published in: Gynecologic Oncology

Volume 123, Issue 3, pp. 499-504

Field-Weighted Citation Impact: 6.93